Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.17M | -4.66M | -4.09M | -3.39M | -3.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 53.70K | 162.10K | 244.00K | 266.90K | 239.90K |
| Total Other Non-Cash Items | 426.80K | 453.00K | 139.10K | -108.50K | 211.60K |
| Change in Net Operating Assets | -90.90K | 78.90K | 46.80K | 388.40K | 2.02M |
| Cash from Operations | -4.78M | -3.96M | -3.66M | -2.84M | -649.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 687.50K | 910.00K | 1.00M |
| Total Debt Repaid | -275.00K | -275.00K | -275.00K | -275.00K | -- |
| Issuance of Common Stock | 7.16M | 6.16M | 6.16M | 6.16M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.68M | -1.46M | -1.59M | -1.59M | -321.40K |
| Cash from Financing | 5.20M | 4.43M | 4.99M | 5.21M | 678.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 425.10K | 463.80K | 1.33M | 2.37M | 29.30K |